Avid Bioservices, Inc. (CDMO) Financial Statements
$12.49NASDAQ: CDMOMarket Cap $798.90M
Avid Bioservices, Inc. most recently reported annual revenue of $140.0M, net profit of $-141.0M, revenue has compounded at 21.0% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.